Studies of Potency and Efficacy of an Optimized Artemisinin-Quinoline Hybrid against Multiple Stages of the Plasmodium Life Cycle

dc.contributor.authorQuadros, Helenita C.
dc.contributor.authorÇapcı, Aysun
dc.contributor.authorHerrmann, Lars
dc.contributor.authorD’Alessandro, Sarah
dc.contributor.authorFontinha, Diana
dc.contributor.authorAzevedo, Raquel
dc.contributor.authorVillarreal, Wilmer
dc.contributor.authorBasilico, Nicoletta
dc.contributor.authorPrudêncio, Miguel
dc.contributor.authorTsogoeva, Svetlana B.
dc.contributor.authorMoreira, Diogo R. M.
dc.date.accessioned2021-12-09
dc.date.available2023-10-11T10:53:32Z
dc.date.created2021
dc.date.issued2021-12-09
dc.description.abstractA recently developed artemisinin-quinoline hybrid, named 163A, has been shown to display potent activity against the asexual blood stage of Plasmodium, the malaria parasite. In this study, we determined its in vitro cytotoxicity to mammalian cells, its potency to suppress P. berghei hepatic infection and to decrease the viability of P. falciparum gametocytes, in addition to determining whether the drug exhibits efficacy of a P. berghei infection in mice. This hybrid compound has a low level of cytotoxicity to mammalian cells and, conversely, a high level of selectivity. It is potent in the prevention of hepatic stage development as well as in killing gametocytes, denoting a potential blockage of malaria transmission. The hybrid presents a potent inhibitory activity for beta-hematin crystal formation, in which subsequent assays revealed that its endoperoxide component undergoes bioactivation by reductive reaction with ferrous heme towards the formation of heme-drug adducts; in parallel, the 7-chloroquinoline component has binding affinity for ferric hemin. Both structural components of the hybrid co-operate to enhance the inhibition of beta-hematin, and this bitopic ligand property is essential for arresting the growth of asexual blood parasites. We demonstrated the in vivo efficacy of the hybrid as an erythrocytic schizonticide agent in comparison to a chloroquine/artemisinin combination therapy. Collectively, the findings suggest that the bitopic property of the hybrid is highly operative on heme detoxification suppression, and this provides compelling evidence for explaining the action of the hybrid on the asexual blood stage. For sporozoite and gametocyte stages, the hybrid conserves the potency typically observed for endoperoxide drugs, and this is possibly achieved due to the redox chemistry of endoperoxide components with ferrous heme.en
dc.identifier.doihttps://doi.org/10.3390/ph14111129
dc.identifier.issn1424-8247
dc.identifier.opus-id17782
dc.identifier.urihttps://open.fau.de/handle/openfau/17782
dc.identifier.urnurn:nbn:de:bvb:29-opus4-177826
dc.language.isoen
dc.publisherMDPI
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/deed.de
dc.subjectmalaria
dc.subjecthemozoin
dc.subjectheterobivalent
dc.subjectartemisinin
dc.subjecthybrids
dc.subject.ddcDDC Classification::5 Naturwissenschaften und Mathematik :: 54 Chemie :: 540 Chemie und zugeordnete Wissenschaften
dc.titleStudies of Potency and Efficacy of an Optimized Artemisinin-Quinoline Hybrid against Multiple Stages of the Plasmodium Life Cycleen
dc.typearticle
dcterms.publisherFriedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
local.date.prevpublished2021-11-06
local.document.articlenumber!!
local.journal.issue11
local.journal.titlePharmaceuticals
local.journal.volume14
local.sendToDnbfree*
local.subject.fakultaetNaturwissenschaftliche Fakultät
local.subject.importimport
local.subject.sammlungUniversität Erlangen-Nürnberg / Eingespielte Open Access Artikel / Eingespielte Open Access Artikel 2021
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
17782_pharmaceuticals-14-01129.pdf
Size:
2.77 MB
Format:
Adobe Portable Document Format
Description: